DNA RNA and Cells

10 Dec 2007 Sangamo BioSciences Announces Presentation of Data for ZFP Therapeutic for Glioblastoma at American Society for Hematology Meeting
10 Dec 2007 Osiris Therapeutics Reports Positive Results for Prochymal(TM) as
05 Dec 2007 Senesco Technologies Initiates Preclinical Studies for Cancer Target
04 Dec 2007 Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
03 Dec 2007 Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis
28 Nov 2007 Geron initiates clinical trial of telomerase inhibitor drug in patients with multiple myeloma
27 Nov 2007 Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
27 Nov 2007 Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis
27 Nov 2007 Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases
26 Nov 2007 Targeted Genetics Announces That FDA Has Removed Hold on Phase I/II Clinical Trial of tgAAC94 for Inflammatory Arthritis
20 Nov 2007 Covalon Achieves Important Milestone in Its Cell-Based Gene Therapy for Treating Congestive Heart Failure and Tissue Regeneration
19 Nov 2007 Quark Announces First Systemic siRNA Dosing
19 Nov 2007 Meyer Pharmaceuticals acquires NF-kappa b decoy technology for treatment of inflammatory disease
15 Nov 2007 Athersys IND for MultiStem Authorized for Phase I Clinical Trial in Bone Marrow Transplant Support
15 Nov 2007 Thallion Announces Positive Safety and Efficacy Data From ECO-4601 Phase I/II Trial
14 Nov 2007 Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
14 Nov 2007 Cardium Initiates Phase 2b Excellarate Clinical Study for Diabetic Ulcers
14 Nov 2007 Invitrogen and CytRx Subsidiary RXi Pharmaceuticals Collaborate to Enhance RNAi Technologies for Therapeutic Applications
13 Nov 2007 Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
13 Nov 2007 Introgen and Gendux Submit First Marketing Authorization Application for ADVEXIN
13 Nov 2007 Archemix Announces Initiation of Phase 2a Trial for Aptamer Product Candidate ARC1779 in Patients with Acute Coronary Syndrome
10 Nov 2007 Targeted Genetics Announces Positive Interim Phase I/II Results for tgAAC94 in Inflammatory Arthritis
07 Nov 2007 Data show Geron’s cell-based therapeutic for spinal cord injury survives and exhibits remyelination for at least nine months following injection
07 Nov 2007 Fresenius Medical Care Announces Continued Positive Data from
07 Nov 2007 Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up